With this contracting file whose conditions are established in the specifications, it is intended to cover the use of the medicine included in the file to meet the clinical needs of Osakidetza patients and related centers and which are summarized in the report's memory.

- Active substance: tigecycline (DOE),

- Amount of active substance: 50 mg,

- Pharmaceutical form: vial,

- Packaging conditions: unit dose,

- Maximum unit price: EUR 21.34 / vial,

- Number of units planned: 4 250 vials,

- Estimated maximum budget: EUR 90 695.00 (first year of contract).